Investing-News.Com
Information for Investors

BAYER AKTIENGES A, (BAY) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

BAYER AKTIENGES A, (BAY) Stock Rating Learn More

Our Overall Rating on BAYER AKTIENGES A,  BAY is Not Available
Bayer AG offers pharmaceuticals, diagnostics and health care products; agricultural products; and polymers. It operates in three groups: HealthCare, CropScience, and MaterialScience. The HealthCare group offers pharmaceuticals products for the treatment of urinary tract infections and severe hospital infections; and for cardiovascular risk management, including diabetes, urology, and oncology. It also provides biological products, such as recombinant protein therapies and blood plasma products. This group also develops consumer care products, such as over the counter medications, vitamins, and nutritional supplements. It also develops diagnostics products that serve in the assessment and management of health in various areas, including infectious diseases, cardiovascular disease, oncology, virology, women’s health, and diabetes, as well as offers products for the health care of animals. The CropScience group provides chemical crop protection products, seeds, and integrated plant biotechnology solutions for agricultural and nonagricultural uses. This group offers insecticides, fungicides, and herbicides for the control of insects, weeds, and fungi, as well as products for professional pest control; and the green industry that include the treatment of golf courses, lawn care, and industrial vegetation management, as well as offers conventional seeds and plant biotechnology products. The MaterialScience group provides polycarbonates, such as polycarbonates, polycarbonate blends, polycarbonate films, and sheets; and thermoplastic polyurethanes granulates. This group offers cellulose derivatives, plastic films, and other additives; and offers a portfolio of products, such as tungsten, molybdenum, tantalum, and niobium, and their alloys and compounds for industrial customers in the aerospace, medical, chemical, electronic, lighting, tooling, and optical components industries. Bayer distributes its products through a network of distributors, governmental agencies, wholesalers, pharmacies, and hospitals, as well as directly to patients in North America, Western Europe, and Asia. The company was formed under the name Farbenfabriken Bayer AG in 1951 and changed its name to Bayer AG in 1972. Bayer is headquartered in Leverkusen, Germany.
Our Not Available Rating on BAY was issued on 11/22/2008

BAYER AKTIENGES A Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces BAYER AKTIENGES A Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in BAYER AKTIENGES A buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on BAYER AKTIENGES A. This software is specially designed to give precision entry and exit points on BAYER AKTIENGES A, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When BAYER AKTIENGES A Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even BAYER AKTIENGES A, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: swing trading stock  stock trading program  www.toddmarketforecast.com 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Pfizer's Nigerian Nightmare (at Forbes.com)

Taking Heart Medicine Beyond Heart Drugs (at Forbes.com)

British Airways says consolidation will speed up (AP)

J&J's High-Wire Heart Drug (at Forbes.com)

A New Age Of Statins? (at Forbes.com)

Bayer Slips But Investors Don't Budge (at Forbes.com)

Bayer Shows Signs Of Weakness (at Forbes.com)

European shares rise sharply in early trading (at MarketWatch)

A pharma deal could offer the right medicine (at FT.com)

Pfizer & Lilly Prove Me Wrong (at CNBC)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.